The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
The Microbiota Makes for Good Therapy: The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967 ) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et al. (p. 971 ) found a similar effect of the microbiota on tumor-bearing mice treated with cyclophosphamide, but in this case it appeared that the microbiota promoted an adaptive immune response against the tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and that therapeutic responses may be improved via its modulation (13, 14)”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [14]
In the citing paper
“The P-ESC was considered representative of baseline microbiome data due to observations that the microbiome of patients treated with anti-PD-1, unlike anti-CTLA-4 or chemotherapy, is stable early after therapy initiation17–19.”
From Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 (2022) · cites this paper as [19]
In the citing paper
“In mouse models, certain gut commensals mediate efficacy of anticancer therapies, including chemotherapy, radiotherapy, and immunotherapies such as adoptive T cell transfer, intratumoral CpG-oligonucleotides, and ICIs.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [3]
In the citing paper
“In addition, broad-spectrum antibiotics (mainly beta-lactams) taken prior to immunotherapy markedly reduce the clinical benefit of ICIs, chimeric antigen receptor (CAR)-T cells, stem cell transplantation in patients, and immunogenic chemotherapy in preclinical tumor models.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [3]
In the citing paper
“The gut microbiome has been shown to have multiple effects on tumor biology, such as the transformation process, tumor progression, and the response to anticancer therapies including immunotherapy (21-29).”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [26]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Finally, monoassociation of tumor-bearing GF mice with SFB, which promotes Th17 cell differentiation in the LP (1, 13, 14) also had a detrimental impact on the tumor growthinhibitory effect of CTX (Fig.”
BackgroundImmunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303 · cited 1×
“Some antineoplastic agents mediate part of their anticancer activity by stimulating anticancer immune responses (6).”
BackgroundSelf-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“S6A) and is required for the therapeutic success of anticancer chemotherapies in several tumor models (19).”
BackgroundSelf-citationInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Self-citation
Research works printed but not linked: 1
- 10.1073/pnas.1113744109 · DOI · Paper page
Cited by
Items 401–500 of 1,012
Classen, A. Y., Henze, L., von Lilienfeld‐Toal, M., Maschmeyer, G., Sandherr, M., Graeff, L. D., Alakel, N., Christopeit, M., Krause, S. W., Mayer, K. T., et al. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04452-9 · Cited by 103
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Cogdill, A. P., Gaudreau, P. O., Arora, R., Gopalakrishnan, V., & Wargo, J. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.09.007 · Cited by 98
Potential effect of probiotics in the treatment of breast cancer
Mendoza, L. (2019) · Oncology Reviews · doi:10.4081/oncol.2019.422 · Cited by 104
Role of the microbiome in occurrence, development and treatment of pancreatic cancer
Wang, Y., Yang, G., You, L., Yang, J., Feng, M., Qiu, J., Zhao, F., Liu, Y., Cao, Z., Zheng, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1103-2 · Cited by 100
Inamura, K., Hamada, T., Bullman, S., Ugai, T., Yachida, S., & Ogino, S. (2022) · Gut · doi:10.1136/gutjnl-2022-327209 · Cited by 100
Effects of microbiota on anticancer drugs: Current knowledge and potential applications
Huang, J., Liu, W., Kang, W., He, Y., Yang, R., Mou, X., & Zhao, W. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104197 · Cited by 103
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Wang, Z., Sun, W., Hua, R., Wang, Y., Li, Y., & Zhang, H. (2024) · International Journal of Oral Science · doi:10.1038/s41368-024-00282-3 · Cited by 97
Sariola, S., & Gilbert, S. F. (2020) · Microorganisms · doi:10.3390/microorganisms8050746 · Cited by 111
The human microbiome and cancer: a diagnostic and therapeutic perspective
Kandalai, S., Li, H., Zhang, N., Peng, H., & Zheng, Q. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2240084 · Cited by 101
Ren, T., Grieneisen, L. E., Alberts, S. C., Archie, E. A., & Wu, M. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.12852 · Cited by 91
Microbiota–drug interactions: Impact on metabolism and efficacy of therapeutics
Wilkinson, E. M., Ilhan, Z. E., & Herbst‐Kralovetz, M. M. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.03.012 · Cited by 102
The Molecular Link from Diet to Cancer Cell Metabolism
Bose, S., Allen, A. E., & Locasale, J. W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.018 · Cited by 90
Gut Microbiota and Breast Cancer: The Dual Role of Microbes
Álvarez‐Mercado, A. I., Cano, A. D. V., Fernández, M. F., & Fontana, L. (2023) · Cancers · doi:10.3390/cancers15020443 · Cited by 104
Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications
Xiao, T., Lee, J., Gauntner, T. D., Velegraki, M., Lathia, J. D., & Li, Z. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00680-z · Cited by 99
Sommer, F., & Bäckhed, F. (2016) · BioEssays · doi:10.1002/bies.201500151 · Cited by 91
The human microbiome in hematopoiesis and hematologic disorders
Manzo, V. E., & Bhatt, A. S. (2015) · Blood · doi:10.1182/blood-2015-04-574392 · Cited by 92
The impact of the intestinal microbiota in therapeutic responses against cancer
Goubet, A., Daillère, R., Routy, B., Derosa, L., Roberti, P. M., & Zitvogel, L. (2018) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2018.03.004 · Cited by 100
Self-citationSu, J., Su, L., Li, D. X., Shuai, O., Zhang, Y., Liang, H., Jiao, C., Xu, Z., Lai, Y. R., & Xie, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01765 · Cited by 99
Rangamuwa, K., Leong, T., Weeden, C. E., Asselin-Labat, M.-L., Bozinovski, S., Christie, M., John, T., Antippa, P. N., Irving, L. B., & Steinfort, D. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1075 · Cited by 95
Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution
Shlyakhtina, Y., Moran, K. L., & Portal, M. M. (2021) · Cancers · doi:10.3390/cancers13061380 · Cited by 102
Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine
Xia, J., Miao, Y., Wang, X., Huang, X., & Dai, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113250 · Cited by 95
Jordan, C. K. I., Brown, R. L., Larkinson, M. L. Y., Sequeira, R. P., Edwards, A. M., & Clarke, T. B. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.07.008 · Cited by 99
Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways
Rabinovich, G. A., & Conejo-Garcia, J. R. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.03.021 · Cited by 100
The role of microbiota in cancer therapy
Perez-Chanona, E., & Trinchieri, G. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.01.003 · Cited by 90
‘As above, so below’ examining the interplay between emotion and the immune system
Brod, S., Rattazzi, L., Piras, G., & D'Acquisto, F. (2014) · Immunology · doi:10.1111/imm.12341 · Cited by 72
SVATON, M., ZEMANOVA, M., ZEMANOVA, P., KULTAN, J., FISCHER, O., SKRICKOVA, J., JAKUBIKOVA, L., CERNOVSKA, M., HRNCIARIK, M., JIROUSEK, M., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14182 · Cited by 88
The Resistance Mechanisms of Lung Cancer Immunotherapy
Wang, F., Wang, S., & Zhou, Q. H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.568059 · Cited by 98
Ortiz, A. M., Klase, Z. A., DiNapoli, S. R., Vujkovic-Cvijin, I., Carmack, K., Perkins, M. R., Calantone, N., Vinton, C. L., Riddick, N. E., Gallagher, J., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.75 · Cited by 99
Ma, W., Zhang, L., Chen, W., Chang, Z., Tu, J., Qin, Y., Yao, Y., Dong, M., Ding, J., Li, S., et al. (2024) · Protein & Cell · doi:10.1093/procel/pwae005 · Cited by 91
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer
Aranda, F., Bloy, N., Pesquet, J., Petit, B., Chaba, K., Sauvat, A., Kepp, O., Khadra, N., Enot, D., Pfirschke, C., et al. (2015) · Oncogene · doi:10.1038/onc.2014.234 · Cited by 89
Self-citationMelanoma and microbiota: Current understanding and future directions
Routy, B., Jackson, T., Mählmann, L., Baumgartner, C. K., Blaser, M., Byrd, A., Corvaia, N., Couts, K., Davar, D., Derosa, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.003 · Cited by 89
Self-citationUnderlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 99
Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment
Pouncey, A. L., Scott, A. J., Alexander, J. L., Marchesi, J. R., & Kinross, J. K. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.868 · Cited by 114
The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
Aarnoutse, R., Ziemons, J., Penders, J., Rensen, S. S., de Vos-Geelen, J., & Smidt, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174145 · Cited by 83
Fidelle, M., Yonekura, S., Picard, M., Cogdill, A., Hollebecque, A., Roberti, M. P., & Zitvogel, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600886 · Cited by 81
Self-citationThe Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
Smet, A., Kupčinskas, J., Link, A., Hold, G. L., & Bornschein, J. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.013 · Cited by 94
The Microbiome and Cancer: A Translational Science Review
Fernandez, E., Wargo, J. A., & Helmink, B. A. (2025) · JAMA · doi:10.1001/jama.2025.2191 · Cited by 95
Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy
Spranger, S., Sivan, A., Corrales, L., & Gajewski, T. F. (2016) · Advances in Immunology · doi:10.1016/bs.ai.2015.12.003 · Cited by 85
Adapting Cancer Immunotherapy Models for the Real World
Klevorn, L. E., & Teague, R. M. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.03.010 · Cited by 88
Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis
Al-Qadami, G. H., Sebille, Y. Z. A. V., Le, H. V., & Bowen, J. M. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1595586 · Cited by 94
Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling
Riquelme, E. M., Maitra, A., & McAllister, F. M. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0123 · Cited by 92
(2015) · PubMed · Cited by 86
Hazas, M. L. D. L., Mosele, J. I., Macià, A., Ludwig, I. A., & Motilva, M. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b04096 · Cited by 86
An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy
Michaud, M., Xie, X., Bravo-San Pedro, J. M., Zitvogel, L., White, E., & Kroemer, G. (2014) · OncoImmunology · doi:10.4161/21624011.2014.944047 · Cited by 80
Self-citationAPC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures
Morcrette, G., Hirsch, T. Z., Badour, E., Pilet, J., Caruso, S., Caldéraro, J., Martin, Y., Imbeaud, S., Letouzé, É., Rebouissou, S., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1583547 · Cited by 85
Iglesias-Santamaría, A. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02282-w · Cited by 90
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe‐Herranz, M., Klein-González, N., Rodríguez‐Lobato, L. G., Juan, M., & de Larrea, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031026 · Cited by 88
Distribution and roles of Ligilactobacillus murinus in hosts
Chuandong, Z., Hu, J., Li, J., Wu, Y., Wu, C., Lai, G., Shen, H., Wu, F., Tao, C., Liu, S., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127648 · Cited by 89
Romano, E., Michielin, O., Voelter, V., Laurent, J., Bichat, H., Stravodimou, A., Romero, P., Speiser, D. E., Triebel, F., Leyvraz, S., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-97 · Cited by 82
Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease
Zhou, A., Lei, Y., Tang, L., Hu, S., Yang, M., Wu, L., Yang, S., & Tang, B. (2020) · Journal of Bacteriology · doi:10.1128/jb.00454-20 · Cited by 89
Gut microbiome in gastrointestinal cancer: a friend or foe?
Liu, Y., Baba, Y., Ishimoto, T., Gu, X. J., Zhang, J., Nomoto, D., Okadome, K., Baba, H., & Qiu, P. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69331 · Cited by 85
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Sun, J., Song, S., Liu, J., Chen, F., Li, X., & Wu, G. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00678-x · Cited by 89
Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies
Li, Y., Yu, T., Huang, Y., Li, D., Yu, T., Yuan, T., Rahaman, A., Ali, S. M., Farhat, A., Dian, Z., et al. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s210615 · Cited by 87
Khan, N., Lindner, S., Gomes, A. L. C., Devlin, S. M., Shah, G. L., Sung, A. D., Sauter, C. S., Landau, H. J., Dahi, P. B., Perales, M., et al. (2020) · Blood · doi:10.1182/blood.2020006923 · Cited by 86
Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?
Finlay, B. B., Goldszmid, R., Honda, K., Trinchieri, G., Wargo, J., & Zitvogel, L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0374-6 · Cited by 81
Self-citationAntibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth
McKee, A. M., Kirkup, B. M., Madgwick, M., Fowler, W. J., Price, C. A., Dreger, S. A., Ansorge, R., Makin, K. A., Caim, S., Le Gall, G., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103012 · Cited by 81
Highley, M., Landuyt, B., Prenen, H., Harper, P., & de Bruijn, E. A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000121 · Cited by 85
The Role of the Microbiome in the Etiopathogenesis of Colon Cancer
Tekle, G. E., Andreeva, N., & Garrett, W. S. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-025619 · Cited by 86
Chen, L., Brar, M. S., Leung, F. C.-C., & Hsiao, W. L. W. (2016) · Oncotarget · doi:10.18632/oncotarget.8886 · Cited by 91
Microbiota as a mediator of cancer progression and therapy
Pope, J. L., Tomkovich, S., Yang, Y., & Jobin, C. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.021 · Cited by 79
Microbiota: a novel regulator of pain
Defaye, M., Gervason, S., Altier, C., Berthon, J., Ardid, D., Filaire, E., & Carvalho, F. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02083-z · Cited by 87
Bioavailability Based on the Gut Microbiota: a New Perspective
Zhang, F., He, F., Li, L., Guo, L., Zhang, B., Yu, S., & Zhao, W. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00072-19 · Cited by 82
Secombe, K. R., Sebille, Y. Z. A. V., Mayo, B. J., Coller, J. K., Gibson, R. J., & Bowen, J. M. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735420928493 · Cited by 81
Mima, K., Ogino, S., Nakagawa, S., Sawayama, H., Kinoshita, K., Krashima, R., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., et al. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.07.011 · Cited by 83
Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Sharma, A., Buschmann, M. M., & Gilbert, J. A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1437 · Cited by 86
Role of intestinal microbiota in transplantation outcomes
Taur, Y., Jenq, R. R., Ubeda, C., van den Brink, M., & Pamer, E. G. (2015) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2015.10.013 · Cited by 79
Jayasinghe, T. N., Chiavaroli, V., Holland, D. J., Cutfield, W. S., & O'Sullivan, J. M. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00015 · Cited by 77
Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment
Yang, X., Guo, Y., Chen, C., Shao, B., Zhao, L., Zhou, Q., Liu, J., Wang, G., Yuan, W., & Sun, Z. (2021) · Immunology · doi:10.1111/imm.13397 · Cited by 86
From Microbiome to Inflammation: The Key Drivers of Cervical Cancer
Zhou, Z., Long, H., Cheng, Y., Luo, H., Wen, D., & Gao, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.767931 · Cited by 83
The virtuous cycle of human genetics and mouse models in drug discovery
Nadeau, J. H., & Auwerx, J. H. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0009-9 · Cited by 84
Tonneau, M., Elkrief, A., Pasquier, D., del Socorro, T. P., Chamaillard, M., Bahig, H., & Routy, B. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.10.033 · Cited by 79
The gut microbiome and efficacy of cancer immunotherapy
Roviello, G., Iannone, L. F., Bersanelli, M., Mini, E., & Catalano, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107973 · Cited by 84
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Zhang, H., Fu, L., Leiliang, X., Qu, C., Wu, W., Wen, R., Huang, N., He, Q., Cheng, Q., Liu, G., et al. (2024) · 癌症:英文版 · doi:10.1002/cac2.12597 · Cited by 78
Sharma, A. K., Jaiswal, S. K., Chaudhary, N., & Sharma, V. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-10203-6 · Cited by 80
Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers
Dong, Z., Abbas, M. N., Kausar, S., Yang, J., Li, L., Tan, L., & Cui, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143577 · Cited by 77
The human gastrointestinal microbiota and prostate cancer development and treatment
Sha, S. T., Ni, L., Stefil, M., Dixon, M. R., & MOURAVIEV, V. B. (2020) · Korean journal of urology · doi:10.4111/icu.2020.61.s1.s43 · Cited by 84
The renaissance of anti‐neoplastic immunity from tumor cell demise
Ma, Y., Pitt, J. M., Li, Q., & Yang, H. (2017) · Immunological Reviews · doi:10.1111/imr.12586 · Cited by 73
Gut microbiota: A new piece in understanding hepatocarcinogenesis
Zhou, A., Tang, L., Zeng, S., Lei, Y., Yang, S., & Tang, B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.002 · Cited by 80
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Samanta, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621999201210220442 · Cited by 81
Zhao, S., Peng, X., Zhou, Q., Huang, Y., Rao, X., Tu, J.-L., Xiao, H.-Y., & Liu, D. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109793 · Cited by 80
Véziant, J., Villéger, R., Barnich, N., & Bonnet, M. (2021) · Cancers · doi:10.3390/cancers13092215 · Cited by 80
Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues
He, Y., Zhang, Q., Yu, X., Zhang, S., & Guo, W. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03938-6 · Cited by 77
Prasad, R., Rehman, A., Rehman, L., Darbaniyan, F., Blumenberg, V., Schubert, M., Mor, U., Zamir, E., Schmidt, S., Hayase, T., et al. (2024) · Blood · doi:10.1182/blood.2024025366 · Cited by 78
VanSeggelen, H., Hammill, J. A., Dvorkin-Gheva, A., Tantalo, D. G., Kwiecien, J. M., Denisova, G. F., Rabinovich, B., Wan, Y., & Bramson, J. L. (2015) · Molecular Therapy · doi:10.1038/mt.2015.119 · Cited by 75
Kuczma, M. P., Ding, Z.-C., Li, T., Habtetsion, T., Chen, T., Hao, Z., Bryan, L., Singh, N., Kochenderfer, J. N., & Zhou, G. (2017) · Oncotarget · doi:10.18632/oncotarget.22953 · Cited by 75
Routy, B., Letendre, C., Enot, D., Chénard-Poirier, M., Mehraj, V., Séguin, N. C., Guenda, K., Gagnon, K., Woerther, P.-L., Ghez, D., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1258506 · Cited by 75
“The gut microbiota may also contribute to the therapeutic response to chemotherapy by mechanisms, which involve bacterial translocation, inflammation, and adaptive immunity.(11,12)”
BackgroundSelf-citationLopes, S., Pabst, L., Dory, A., Klotz, M., Gourieux, B., Michel, B., & Mascaux, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1070076 · Cited by 75
“fragilis, which activated Th1 cells and cross-reactivity between bacterial antigens and tumor antigens (68).”
BackgroundInfluence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
Chen, Y., Liu, B., Wei, Y., & Kuang, D.-M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105966 · Cited by 73
The microbiome in anti-cancer therapy
Bashiardes, S., Tuganbaev, T., Federici, S., & Elinav, E. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.04.001 · Cited by 80
Zhu, G., Jiang, Y., Yao, Y., Wu, N., Luo, J., Hu, M., Tu, Y., & Xu, M. (2019) · Food & Function · doi:10.1039/c8fo02312c · Cited by 75
Sampsell, K., Hao, D., & Reimer, R. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239239 · Cited by 81
Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction
Wang, W., Wang, J., Li, J., Yan, P., Jin, Y., Zhang, R., Yue, W., Guo, Q., & Geng, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01402 · Cited by 76
Galli, G., Triulzi, T., Proto, C., Signorelli, D., Imbimbo, M., Poggi, M. M., Fucà, G., Ganzinelli, M., Vitali, M., Palmieri, D., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.04.008 · Cited by 76
Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota
Frankel, A. E., Deshmukh, S. K., Reddy, A., Lightcap, J., Hayes, M., McClellan, S. B., Singh, S., Rabideau, B. D., Glover, T. G., Roberts, B., et al. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419846379 · Cited by 76
Shi, F., Lu, Z., Yang, M., Li, F., Zhan, F., Zhao, L., Li, Y., Li, Q., Li, J., Li, J., et al. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.736205 · Cited by 76
The potential role of the microbiota in prostate cancer pathogenesis and treatment
Pernigoni, N., Guo, C. W., Gallagher, L., Yuan, W., Colucci, M., Troiani, M., Liu, L., Maraccani, L., Guccini, I., Migliorini, D., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00795-2 · Cited by 77
Leite, M. L., da Cunha, N. B., & Costa, F. F. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.010 · Cited by 75
Shi, W., Shen, L., Zou, W., Wang, J., Yang, J., Wang, Y., Liu, B., Xie, L., Zhu, J. Y., & Zhang, Z. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.562463 · Cited by 74
Gut microbiome in pediatric acute leukemia: from predisposition to cure
Masetti, R., Muratore, E., Leardini, D., Zama, D., Turroni, S., Brigidi, P., Esposito, S., & Pession, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005129 · Cited by 74
Human Gut Microbiota in Health and Selected Cancers
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413440 · Cited by 76
Metadata
- Authors
- Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., Schlitzer, A., Ginhoux, F., Apetoh, L., Chachaty, E., Woerther, P.-L., Eberl, G., Bérard, M., Ecobichon, C., Clermont, D., Bizet, C., Gaboriau-Routhiau, V., Cerf-Bensussan, N., Opolon, P., Yessaad, N., Vivier, E., Ryffel, B., Elson, C. O., Doré, J., Kroemer, G., Lepage, P., Boneca, I. G., Ghiringhelli, F., & Zitvogel, L.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Harvard University (US)
- Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Agency for Science, Technology and Research (SG)
- Institut National de la Santé et de la Recherche Médicale, U866, Centre Georges François Leclerc, Dijon, France.
- Service de Microbiologie, Institut Gustave Roussy, Villejuif, France.
- Institut Gustave Roussy (FR)
- Institut Pasteur (FR)
- Nimalerie Centrale, Institut Pasteur, Paris, France.
- Institut National de la Recherche Agronomique, Micalis–UMR1319, 78350 Jouy-en-Josas, France.
- Centre National de la Recherche Scientifique (FR)
- Centre d’Immunologie de Marseille-Luminy, Aix-Marseille Université UM2, Marseille, France.
- Université d'Orléans (FR)
- University of Alabama at Birmingham (US)
- AgroParisTech (FR)
- Corresponding author
- Ghiringhelli, François
- Zitvogel, Laurence
- ORCID
- Mignot, Grégoire
- Yamazaki, Takahiro
- Daillère, Romain
- Hannani, Dalil
- Pfirschke, Christina
- Engblom, Camilla
- Schlitzer, Andreas
- Ginhoux, Florent
- Woerther, Paul-Louis
- Eberl, Gérard
- Clermont, Dominique
- Opolon, Paule
- Ryffel, Bernhard
- Elson, Charles O.
- Kroemer, Guido
- Lepage, Patricia
- Boneca, Ivo Gomperts
- Ghiringhelli, François
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2013-11-22
- Volume
- 342
- Issue
- 6161
- Pages
- 971-976
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4048947
- OpenAlex
- W2059128083
- Cited by
- 2,050
- References
- 43
- Citations by year
- 2026: 109 · 2025: 165 · 2024: 176 · 2023: 216 · 2022: 234 · 2021: 217 · 2020: 220 · 2019: 183 · 2018: 137 · 2017: 116 · 2016: 98 · 2015: 101 · 2014: 69 · 2013: 6
- FWCI
- 40.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- HAL AMU (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-11-PHUC-0002)
- National Cancer Institute (P50CA086355)
- National Institute of Allergy and Infectious Diseases (R01AI084880)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK071176)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- cyclophosphamide, gut microbiota, antitumor immunity, Gram-positive bacteria, Th17 cells, memory T cells, secondary lymphoid organs, bacterial translocation, germ-free mice, antibiotic therapy, adoptive transfer, small intestine
- MeSH terms
- Animals, Anti-Bacterial Agents, Antineoplastic Agents, Cyclophosphamide, Germ-Free Life, Gram-Positive Bacteria, Immunologic Memory, Immunosuppressive Agents, Intestine, Small, Lymphoid Tissue, Neoplasms, Bacterial Translocation, Adoptive Transfer, Mice, Th17 Cells, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.